Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Connolly

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Journal of Neuromuscular Diseases|August 23, 2021
A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen TreatmentOlga Mitelman, Hoda Z Abdel-Hamid, Barry J Byrne, et al.
Neurogenetics|April 21, 2016
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defectsDavid B Beck, Megan T Cho, Francisca Millan, et al.
Pediatric Neurology|May 21, 2014
One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler developmentAnne M Connolly, Julaine M Florence, Mary M Cradock, et al.
Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.
Journal of Neuromuscular Diseases|April 12, 2024
Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular DystrophyCraig M Zaidman, Natalie L Goedeker, Amal A Aqul, et al.
Annals of Clinical and Translational Neurology|April 28, 2025
Validity and Reliability of Clinical and Patient-Reported Outcomes in Multisystem Proteinopathy 1Lindsay N Alfano, Megan A Iammarino, Natalie F Reash, et al.
Journal of Child Neurology|April 12, 2013
Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workupMichael M Segal, Marc S Williams, Andrea L Gropman, et al.
Muscle & Nerve|January 2, 2025
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center ExperienceCan Ebru Bekircan-Kurt, Sharmada Subramanian, Shannon Chagat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac functionKristin P Bibee, Ya-Jian Cheng, James K Ching, et al.
Journal of Neuromuscular Diseases|February 20, 2025
Gross motor delays in infants and young boys with Duchenne muscular dystrophyLinda P Lowes, Natalie F Reash, Megan A Iammarino, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Journal of Neuromuscular Diseases|August 23, 2021
A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen TreatmentOlga Mitelman, Hoda Z Abdel-Hamid, Barry J Byrne, et al.
Neurogenetics|April 21, 2016
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defectsDavid B Beck, Megan T Cho, Francisca Millan, et al.
Pediatric Neurology|May 21, 2014
One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler developmentAnne M Connolly, Julaine M Florence, Mary M Cradock, et al.
Muscle & Nerve|April 25, 2020
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemicAravindhan Veerapandiyan, Kathryn R Wagner, Susan Apkon, et al.
Journal of Neuromuscular Diseases|April 12, 2024
Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular DystrophyCraig M Zaidman, Natalie L Goedeker, Amal A Aqul, et al.
Annals of Clinical and Translational Neurology|April 28, 2025
Validity and Reliability of Clinical and Patient-Reported Outcomes in Multisystem Proteinopathy 1Lindsay N Alfano, Megan A Iammarino, Natalie F Reash, et al.
Journal of Child Neurology|April 12, 2013
Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workupMichael M Segal, Marc S Williams, Andrea L Gropman, et al.
Muscle & Nerve|January 2, 2025
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center ExperienceCan Ebru Bekircan-Kurt, Sharmada Subramanian, Shannon Chagat, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2014
Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac functionKristin P Bibee, Ya-Jian Cheng, James K Ching, et al.
Journal of Neuromuscular Diseases|February 20, 2025
Gross motor delays in infants and young boys with Duchenne muscular dystrophyLinda P Lowes, Natalie F Reash, Megan A Iammarino, et al.
Pageof 12